NovaBridge Biosciences (NBP) Goodwill & Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Goodwill & Intangibles for 6 consecutive years, with $16.4 million the latest figure, recorded in Q4 2023.

• In Q4 2023, Goodwill & Intangibles fell 58.55% year-over-year to $16.4 million; the TTM figure through Dec 2023 stood at $16.4 million (down 58.55% YoY), while the FY2023 annual figure was $16.7 million, down 57.77% from the prior year.
• Goodwill & Intangibles retreated to $16.4 million in Q4 2023 per NBP's latest filing, from $40.1 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $44.1 billion in Q4 2021 and bottomed at $16.4 million in Q4 2023.
• Historically, Goodwill & Intangibles has averaged $4.5 billion across 5 years, with a median of $42.7 million in 2020.
• Annual changes were most pronounced in 2021 — Goodwill & Intangibles jumped 103270.82% — and 2022, when it plunged 99.91%.
• NovaBridge Biosciences' Goodwill & Intangibles stood at $44.2 million in 2019, then decreased by 3.35% to $42.7 million in 2020, then surged by 103270.82% to $44.1 billion in 2021, then plunged by 99.91% to $39.6 million in 2022, then slumped by 58.55% to $16.4 million in 2023.
• Business Quant data shows NBP's Goodwill & Intangibles at $16.4 million in Q4 2023, $40.1 million in Q2 2023, and $39.6 million in Q4 2022.